Thomas R. Miller

3.4k total citations
84 papers, 2.5k citations indexed

About

Thomas R. Miller is a scholar working on Molecular Biology, Immunology and General Health Professions. According to data from OpenAlex, Thomas R. Miller has authored 84 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 24 papers in Immunology and 11 papers in General Health Professions. Recurrent topics in Thomas R. Miller's work include Mast cells and histamine (24 papers), Receptor Mechanisms and Signaling (24 papers) and Healthcare Policy and Management (10 papers). Thomas R. Miller is often cited by papers focused on Mast cells and histamine (24 papers), Receptor Mechanisms and Signaling (24 papers) and Healthcare Policy and Management (10 papers). Thomas R. Miller collaborates with scholars based in United States, United Kingdom and Lebanon. Thomas R. Miller's co-authors include Fredric D. Wolinsky, Timothy A. Esbenshade, Arthur A. Hancock, Robert W. Schrier, David G. Witte, Robert L. Ohsfeldt, Herbert E. Kaufman, Antonio R. Gasset, Kathleen M. Krueger and Arnold S. Berns and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Thomas R. Miller

81 papers receiving 2.3k citations

Peers

Thomas R. Miller
Asya Lyass United States
Robert L. Jesse United States
W. Lorenz Germany
Randie R. Little United States
Richard N. Ré United States
Ann Chen Wu United States
A. Titia Lely Netherlands
Matthew A. Sparks United States
David J. Hirsch Canada
Harry Campbell United Kingdom
Asya Lyass United States
Thomas R. Miller
Citations per year, relative to Thomas R. Miller Thomas R. Miller (= 1×) peers Asya Lyass

Countries citing papers authored by Thomas R. Miller

Since Specialization
Citations

This map shows the geographic impact of Thomas R. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas R. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas R. Miller more than expected).

Fields of papers citing papers by Thomas R. Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas R. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas R. Miller. The network helps show where Thomas R. Miller may publish in the future.

Co-authorship network of co-authors of Thomas R. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas R. Miller. A scholar is included among the top collaborators of Thomas R. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas R. Miller. Thomas R. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paolone, Giovanna, Caitlin S. Mallory, Ajeesh Koshy Cherian, et al.. (2013). Monitoring cholinergic activity during attentional performance in mice heterozygous for the choline transporter: A model of cholinergic capacity limits. Neuropharmacology. 75. 274–285. 19 indexed citations
2.
Phillips, Charles D., Darcy Jones McMaughan, James A. Dyer, et al.. (2012). Summarizing activity limitations in children with chronic illnesses living in the community: a measurement study of scales using supplemented interRAI items. BMC Health Services Research. 12(1). 19–19. 27 indexed citations
3.
Elliott, Timothy R., Darcy Jones McMaughan, Thomas R. Miller, et al.. (2011). Severity of children's intellectual disabilities and Medicaid personal care services.. Rehabilitation Psychology. 56(4). 383–390. 14 indexed citations
4.
Liu, Huaqing, Robert J. Altenbach, Gilbert Diaz, et al.. (2010). In vitro studies on a class of quinoline containing histamine H3 antagonists. Bioorganic & Medicinal Chemistry Letters. 20(11). 3295–3300. 9 indexed citations
5.
Miller, Thomas R., John L. Baranowski, David G. Witte, et al.. (2008). A Robust and High-Capacity [ 35 S]GTP γ S Binding Assay for Determining Antagonist and Inverse Agonist Pharmacological Parameters of Histamine H 3 Receptor Ligands. Assay and Drug Development Technologies. 6(3). 339–349. 5 indexed citations
6.
Strakhova, Marina I., Gerard B. Fox, Tracy L. Carr, et al.. (2008). Cloning and characterization of the monkey histamine H3 receptor isoforms. European Journal of Pharmacology. 601(1-3). 8–15. 10 indexed citations
7.
Wolinsky, Fredric D., Thomas R. Miller, Hyonggin An, et al.. (2007). Hospital Episodes and Physician Visits. Medical Care. 45(4). 300–307. 81 indexed citations
8.
Wolinsky, Fredric D., Liu Li, Thomas R. Miller, et al.. (2007). The use of chiropractors by older adults in the United States. SHILAP Revista de lepidopterología. 15(1). 12–12. 26 indexed citations
9.
10.
Wolinsky, Fredric D., et al.. (2006). Dual use of Medicare and the Veterans Health Administration: are there adverse health outcomes?. BMC Health Services Research. 6(1). 131–131. 82 indexed citations
11.
Pan, Jia Bao, Betty Yao, Thomas R. Miller, et al.. (2006). Evidence for tolerance following repeated dosing in rats with ciproxifan, but not with A-304121. Life Sciences. 79(14). 1366–1379. 12 indexed citations
12.
Ward, Marcia M., Mirou Jaana, Douglas S. Wakefield, et al.. (2004). What Would Be the Effect of Referral to High‐Volume Hospitals in a Largely Rural State?. The Journal of Rural Health. 20(4). 344–354. 71 indexed citations
13.
Leonard, Karen Moustafa & Thomas R. Miller. (2003). Too intelligent for the job? The validity of upper limit cognitive test scores in selection. Opus: Research & Creativity (Indiana University – Purdue University Fort Wayne). 68(2). 4. 3 indexed citations
14.
Gopalakrishnan, Murali, Thomas R. Miller, Steven A. Buckner, et al.. (2003). Pharmacological characterization of a 1,4‐dihydropyridine analogue, 9‐(3,4‐dichlorophenyl)‐3,3,6,6‐tetramethyl‐3,4,6,7,9,10‐hexahydro‐1,8(2H,5H)‐acridinedione (A‐184209) as a novel KATP channel inhibitor. British Journal of Pharmacology. 138(2). 393–399. 9 indexed citations
15.
Faghih, Ramin, Robert G. Gentles, Timothy A. Esbenshade, et al.. (2002). Structure–activity relationships of non-imidazole H3 receptor ligands. Part 1. Bioorganic & Medicinal Chemistry Letters. 12(15). 2031–2034. 23 indexed citations
16.
Miller, Thomas R., Ute Wittstock, Ulrike Lindequist, & Eberhard Teuscher. (1996). Effects of some Components of the Essential Oil of Chamomile,Chamomilla recutita, on Histamine Release from Rat Mast Cells. Planta Medica. 62(1). 60–61. 38 indexed citations
17.
Elliott, Richard L., Hana Kopecka, Michael J. Bennett, et al.. (1994). Tetrapeptide CCK agonists: structure-activity studies on modifications at the N-terminus. Journal of Medicinal Chemistry. 37(2). 309–313. 9 indexed citations
18.
Shue, Youe‐Kong, Michael D. Tufano, George M. Carrera, et al.. (1993). Double bond isosteres of the peptide bond: Synthesis and biological activity of cholecystokinin (CCK) C-terminal hexapeptide analogs. Bioorganic & Medicinal Chemistry. 1(3). 161–171. 6 indexed citations
19.
Shiosaki, Kazumi, Chun Wel Lin, Hana Kopecka, et al.. (1992). Development of potent and selective CCK-A receptor agonists from Boc-CCK-4: tetrapeptides containing Lys(N.epsilon.)-amide residues. Journal of Medicinal Chemistry. 35(11). 2007–2014. 6 indexed citations
20.
Miller, Thomas R.. (1972). Fusiform Rust in Planted Slash Pines: Influence of Site Preparation and Spacing. Forest Science. 18(1). 70–75.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Asya Lyass Breakdown of academic impact, for papers by Robert L. Jesse Breakdown of academic impact, for papers by W. Lorenz Breakdown of academic impact, for papers by Randie R. Little Breakdown of academic impact, for papers by Richard N. Ré Breakdown of academic impact, for papers by Ann Chen Wu Breakdown of academic impact, for papers by A. Titia Lely Breakdown of academic impact, for papers by Matthew A. Sparks Breakdown of academic impact, for papers by David J. Hirsch Breakdown of academic impact, for papers by Harry Campbell
Rankless by CCL
2026